Cargando…

IN VITRO STIMULATION OF ANTIBODY FORMATION BY PERITONEAL CELLS : II. CELL INTERACTIONS AND EFFECTS OF IMMUNOCHEMICAL OR METABOLIC INHIBITORS

Peritoneal cells (PC) from normal, unimmunized mice were placed in ultra-thin monolayer cultures containing carboxymethylcellulose (CMC), sheep red blood cells (SRBC), and complement, and tested for the appearance of plaques of lysis. The behavior of PC from young male mice and from female mice that...

Descripción completa

Detalles Bibliográficos
Autores principales: Bussard, A. E., Nossal, G. J. V., Mazie, J. C., Lewis, H.
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 1970
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2138833/
https://www.ncbi.nlm.nih.gov/pubmed/4910144
_version_ 1782143655175258112
author Bussard, A. E.
Nossal, G. J. V.
Mazie, J. C.
Lewis, H.
author_facet Bussard, A. E.
Nossal, G. J. V.
Mazie, J. C.
Lewis, H.
author_sort Bussard, A. E.
collection PubMed
description Peritoneal cells (PC) from normal, unimmunized mice were placed in ultra-thin monolayer cultures containing carboxymethylcellulose (CMC), sheep red blood cells (SRBC), and complement, and tested for the appearance of plaques of lysis. The behavior of PC from young male mice and from female mice that had given birth to several litters (retired breeder mice) was studied. It was found that cells from spleen, mesenteric lymph node, thymus, bone marrow, thoracic duct lymph, or Peyer's patches could not form plaques in the CMC microcultures. Also, various combinations of these cells did not lead to plaque formation. When cells from any of these sources were mixed with PC, there was either no effect or an actual inhibition of plaque formation, the plaque counts being lower than would have been expected from the number of PC present in the mixture. Optimal plaque formation by peritoneal cells was found to be dependent on an optimal cell concentration, this optimum being around 5 x 10(6)/ml for young male mice and 0.5 x 10(6)/ml for retired breeders. Inhibition of plaque formation was found with either supra- or suboptimal cell concentrations. The inhibition by excess cell concentration may have been a simple nutritional or nonspecific overcrowding effect, as it could also be induced by an addition of an excess of spleen or lymph node cells. The failure of more dilute PC preparations to give adequate numbers of plaques appeared to be more specific, as plaque numbers could not be restored to normal by addition of spleen cells. The suggestion was that some cell to cell interaction between PC was involved. This dependence on cell concentration was not seen with immunized spleen PFC. Plaque appearance could be specifically and reversibly suppressed by placing PC in a medium containing rabbit anti-mouse IgM serum. Anti-IgG serum had no such effect. These experiments strengthened our view, expressed in the accompanying paper, that plaque formation was due to the formation of IgM, hemolytic antibody to SRBC by the PC. Metabolic inhibitors were incorporated into monolayer cultures and had different effects with the different types of PFC used. In the case of spleen cells from mice actively immunized against SRBC 4 days before killing, actinomycin D had no effect on plaque counts and puromycin reduced plaque numbers by a factor of 2. In the case of PC from young male mice, actinomycin D in concentrations above 0.01 µg/ml caused reductions down to < 2% of control values in plaque counts, and puromycin (10 µg/ml) had a similar effect. The PC from retired breeder mice occupied an intermediate position between the two cases just discussed. A compartment of cells, equal to about one-fifth of the total normal PFC compartment, was identified as resistant to high concentrations of either actinomycin D or puromycin, being similar in these respects to PFC from spleens of intentionally preimmunized mice. The mitotic poison, Colcemid, did not affect plaque counts in any situation tested. The theoretical implications of these results are briefly discussed.
format Text
id pubmed-2138833
institution National Center for Biotechnology Information
language English
publishDate 1970
publisher The Rockefeller University Press
record_format MEDLINE/PubMed
spelling pubmed-21388332008-04-17 IN VITRO STIMULATION OF ANTIBODY FORMATION BY PERITONEAL CELLS : II. CELL INTERACTIONS AND EFFECTS OF IMMUNOCHEMICAL OR METABOLIC INHIBITORS Bussard, A. E. Nossal, G. J. V. Mazie, J. C. Lewis, H. J Exp Med Article Peritoneal cells (PC) from normal, unimmunized mice were placed in ultra-thin monolayer cultures containing carboxymethylcellulose (CMC), sheep red blood cells (SRBC), and complement, and tested for the appearance of plaques of lysis. The behavior of PC from young male mice and from female mice that had given birth to several litters (retired breeder mice) was studied. It was found that cells from spleen, mesenteric lymph node, thymus, bone marrow, thoracic duct lymph, or Peyer's patches could not form plaques in the CMC microcultures. Also, various combinations of these cells did not lead to plaque formation. When cells from any of these sources were mixed with PC, there was either no effect or an actual inhibition of plaque formation, the plaque counts being lower than would have been expected from the number of PC present in the mixture. Optimal plaque formation by peritoneal cells was found to be dependent on an optimal cell concentration, this optimum being around 5 x 10(6)/ml for young male mice and 0.5 x 10(6)/ml for retired breeders. Inhibition of plaque formation was found with either supra- or suboptimal cell concentrations. The inhibition by excess cell concentration may have been a simple nutritional or nonspecific overcrowding effect, as it could also be induced by an addition of an excess of spleen or lymph node cells. The failure of more dilute PC preparations to give adequate numbers of plaques appeared to be more specific, as plaque numbers could not be restored to normal by addition of spleen cells. The suggestion was that some cell to cell interaction between PC was involved. This dependence on cell concentration was not seen with immunized spleen PFC. Plaque appearance could be specifically and reversibly suppressed by placing PC in a medium containing rabbit anti-mouse IgM serum. Anti-IgG serum had no such effect. These experiments strengthened our view, expressed in the accompanying paper, that plaque formation was due to the formation of IgM, hemolytic antibody to SRBC by the PC. Metabolic inhibitors were incorporated into monolayer cultures and had different effects with the different types of PFC used. In the case of spleen cells from mice actively immunized against SRBC 4 days before killing, actinomycin D had no effect on plaque counts and puromycin reduced plaque numbers by a factor of 2. In the case of PC from young male mice, actinomycin D in concentrations above 0.01 µg/ml caused reductions down to < 2% of control values in plaque counts, and puromycin (10 µg/ml) had a similar effect. The PC from retired breeder mice occupied an intermediate position between the two cases just discussed. A compartment of cells, equal to about one-fifth of the total normal PFC compartment, was identified as resistant to high concentrations of either actinomycin D or puromycin, being similar in these respects to PFC from spleens of intentionally preimmunized mice. The mitotic poison, Colcemid, did not affect plaque counts in any situation tested. The theoretical implications of these results are briefly discussed. The Rockefeller University Press 1970-05-01 /pmc/articles/PMC2138833/ /pubmed/4910144 Text en Copyright © 1970 by The Rockefeller University Press This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/).
spellingShingle Article
Bussard, A. E.
Nossal, G. J. V.
Mazie, J. C.
Lewis, H.
IN VITRO STIMULATION OF ANTIBODY FORMATION BY PERITONEAL CELLS : II. CELL INTERACTIONS AND EFFECTS OF IMMUNOCHEMICAL OR METABOLIC INHIBITORS
title IN VITRO STIMULATION OF ANTIBODY FORMATION BY PERITONEAL CELLS : II. CELL INTERACTIONS AND EFFECTS OF IMMUNOCHEMICAL OR METABOLIC INHIBITORS
title_full IN VITRO STIMULATION OF ANTIBODY FORMATION BY PERITONEAL CELLS : II. CELL INTERACTIONS AND EFFECTS OF IMMUNOCHEMICAL OR METABOLIC INHIBITORS
title_fullStr IN VITRO STIMULATION OF ANTIBODY FORMATION BY PERITONEAL CELLS : II. CELL INTERACTIONS AND EFFECTS OF IMMUNOCHEMICAL OR METABOLIC INHIBITORS
title_full_unstemmed IN VITRO STIMULATION OF ANTIBODY FORMATION BY PERITONEAL CELLS : II. CELL INTERACTIONS AND EFFECTS OF IMMUNOCHEMICAL OR METABOLIC INHIBITORS
title_short IN VITRO STIMULATION OF ANTIBODY FORMATION BY PERITONEAL CELLS : II. CELL INTERACTIONS AND EFFECTS OF IMMUNOCHEMICAL OR METABOLIC INHIBITORS
title_sort in vitro stimulation of antibody formation by peritoneal cells : ii. cell interactions and effects of immunochemical or metabolic inhibitors
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2138833/
https://www.ncbi.nlm.nih.gov/pubmed/4910144
work_keys_str_mv AT bussardae invitrostimulationofantibodyformationbyperitonealcellsiicellinteractionsandeffectsofimmunochemicalormetabolicinhibitors
AT nossalgjv invitrostimulationofantibodyformationbyperitonealcellsiicellinteractionsandeffectsofimmunochemicalormetabolicinhibitors
AT maziejc invitrostimulationofantibodyformationbyperitonealcellsiicellinteractionsandeffectsofimmunochemicalormetabolicinhibitors
AT lewish invitrostimulationofantibodyformationbyperitonealcellsiicellinteractionsandeffectsofimmunochemicalormetabolicinhibitors